Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bioethics | 7 | 2017 | 9 | 1.790 |
Why?
|
| Ethics, Research | 5 | 2019 | 18 | 1.370 |
Why?
|
| Health Status Disparities | 5 | 2020 | 719 | 1.120 |
Why?
|
| Bioethical Issues | 2 | 2017 | 6 | 0.930 |
Why?
|
| Universities | 5 | 2019 | 559 | 0.900 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 310 | 0.880 |
Why?
|
| Public Health | 2 | 2018 | 424 | 0.700 |
Why?
|
| Research | 3 | 2022 | 181 | 0.700 |
Why?
|
| Biomedical Research | 5 | 2024 | 502 | 0.670 |
Why?
|
| Famous Persons | 1 | 2019 | 5 | 0.590 |
Why?
|
| Social Justice | 2 | 2017 | 65 | 0.570 |
Why?
|
| Ethics Committees, Research | 2 | 2016 | 11 | 0.550 |
Why?
|
| Mental Competency | 1 | 2017 | 12 | 0.540 |
Why?
|
| Ethicists | 1 | 2017 | 5 | 0.540 |
Why?
|
| Hela Cells | 1 | 2019 | 376 | 0.540 |
Why?
|
| Advance Care Planning | 1 | 2017 | 20 | 0.530 |
Why?
|
| Advance Directives | 1 | 2017 | 33 | 0.530 |
Why?
|
| Disasters | 1 | 2018 | 79 | 0.530 |
Why?
|
| Morals | 4 | 2020 | 15 | 0.510 |
Why?
|
| Humans | 31 | 2025 | 43102 | 0.490 |
Why?
|
| Cooperative Behavior | 2 | 2010 | 269 | 0.460 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 252 | 0.450 |
Why?
|
| Vulnerable Populations | 3 | 2019 | 166 | 0.430 |
Why?
|
| Minority Groups | 2 | 2019 | 690 | 0.430 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 415 | 0.430 |
Why?
|
| Socioeconomic Factors | 4 | 2023 | 1234 | 0.420 |
Why?
|
| Alabama | 7 | 2020 | 52 | 0.410 |
Why?
|
| Interinstitutional Relations | 2 | 2013 | 51 | 0.350 |
Why?
|
| Neoplasms | 4 | 2022 | 1377 | 0.340 |
Why?
|
| Genome, Human | 2 | 2023 | 144 | 0.340 |
Why?
|
| Communication | 1 | 2010 | 210 | 0.280 |
Why?
|
| Informed Consent | 2 | 2019 | 35 | 0.280 |
Why?
|
| Patient Participation | 2 | 2024 | 94 | 0.270 |
Why?
|
| Health Care Sector | 1 | 2006 | 10 | 0.250 |
Why?
|
| Congresses as Topic | 2 | 2019 | 50 | 0.240 |
Why?
|
| Coercion | 1 | 2006 | 11 | 0.240 |
Why?
|
| Terminal Care | 1 | 2006 | 54 | 0.240 |
Why?
|
| Prejudice | 1 | 2006 | 116 | 0.230 |
Why?
|
| Cardiac Electrophysiology | 1 | 2025 | 3 | 0.230 |
Why?
|
| Endpoint Determination | 1 | 2025 | 8 | 0.230 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2025 | 9 | 0.230 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2025 | 42 | 0.220 |
Why?
|
| Community Networks | 2 | 2013 | 107 | 0.220 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 148 | 0.220 |
Why?
|
| Neurosciences | 1 | 2024 | 34 | 0.210 |
Why?
|
| South Africa | 1 | 2023 | 38 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 375 | 0.200 |
Why?
|
| Tissue and Organ Procurement | 1 | 2004 | 54 | 0.200 |
Why?
|
| Human Experimentation | 1 | 2003 | 11 | 0.190 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 101 | 0.190 |
Why?
|
| Academies and Institutes | 1 | 2003 | 39 | 0.190 |
Why?
|
| Research Subjects | 1 | 2003 | 35 | 0.190 |
Why?
|
| Genomics | 2 | 2024 | 293 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 590 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2020 | 17 | 0.170 |
Why?
|
| Community-Institutional Relations | 1 | 2003 | 219 | 0.160 |
Why?
|
| Patient Access to Records | 1 | 2019 | 1 | 0.150 |
Why?
|
| Genetic Privacy | 1 | 2019 | 2 | 0.150 |
Why?
|
| Medical Oncology | 1 | 2019 | 50 | 0.150 |
Why?
|
| Virginia | 1 | 2019 | 12 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 193 | 0.140 |
Why?
|
| Biopsy | 1 | 2019 | 177 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 31 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 28 | 0.120 |
Why?
|
| Teaching | 1 | 2016 | 59 | 0.120 |
Why?
|
| Research Personnel | 1 | 2016 | 206 | 0.110 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.100 |
Why?
|
| Minority Health | 1 | 2013 | 95 | 0.100 |
Why?
|
| Syphilis | 1 | 2012 | 24 | 0.090 |
Why?
|
| Research Design | 2 | 2025 | 385 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 1723 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2010 | 208 | 0.070 |
Why?
|
| United States | 3 | 2019 | 5205 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 706 | 0.070 |
Why?
|
| Female | 4 | 2024 | 24698 | 0.070 |
Why?
|
| Humanities | 1 | 2006 | 1 | 0.060 |
Why?
|
| Conflict of Interest | 1 | 2006 | 11 | 0.060 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 128 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2006 | 156 | 0.060 |
Why?
|
| Checklist | 1 | 2025 | 17 | 0.060 |
Why?
|
| Trust | 1 | 2006 | 167 | 0.050 |
Why?
|
| Genetic Research | 1 | 2024 | 11 | 0.050 |
Why?
|
| Video Recording | 1 | 2024 | 41 | 0.050 |
Why?
|
| Resource Allocation | 1 | 2004 | 14 | 0.050 |
Why?
|
| Health Personnel | 1 | 2006 | 277 | 0.050 |
Why?
|
| Male | 3 | 2024 | 23409 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 259 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 199 | 0.040 |
Why?
|
| Ownership | 1 | 2019 | 12 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 164 | 0.040 |
Why?
|
| Rural Population | 1 | 2022 | 373 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 91 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 192 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2019 | 246 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1759 | 0.030 |
Why?
|
| Arthritis-Encephalitis Virus, Caprine | 1 | 1995 | 1 | 0.030 |
Why?
|
| Lentivirus Infections | 1 | 1995 | 2 | 0.030 |
Why?
|
| Goat Diseases | 1 | 1995 | 6 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 1995 | 8 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1600 | 0.030 |
Why?
|
| Catalase | 1 | 1995 | 110 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 1995 | 112 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 934 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1995 | 158 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 64 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 12222 | 0.030 |
Why?
|
| Child | 1 | 2020 | 3443 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 178 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 13872 | 0.020 |
Why?
|
| Antioxidants | 1 | 1995 | 443 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2853 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1413 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 1596 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 8214 | 0.010 |
Why?
|
| HIV Infections | 1 | 1995 | 2586 | 0.010 |
Why?
|
| Cachexia | 1 | 1995 | 7 | 0.010 |
Why?
|
| Goats | 1 | 1995 | 23 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1995 | 64 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1995 | 64 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1995 | 190 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1154 | 0.010 |
Why?
|
| Animals | 1 | 1995 | 16992 | 0.000 |
Why?
|